Related references
Note: Only part of the references are listed.Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis
Yusuke Sakaguchi et al.
KIDNEY INTERNATIONAL (2014)
Proton pump inhibitors and hypomagnesemia: a rare but serious complication
Mark A. Perazella
KIDNEY INTERNATIONAL (2013)
Proton-pump inhibitor use is associated with low serum magnesium concentrations
John Danziger et al.
KIDNEY INTERNATIONAL (2013)
Relationship between Serum Magnesium Levels and Cardiovascular Events in Chronic Kidney Disease Patients
Mehmet Kanbay et al.
AMERICAN JOURNAL OF NEPHROLOGY (2012)
Modeling and Simulation of the Effect of Proton Pump Inhibitors on Magnesium Homeostasis. 1. Oral Absorption of Magnesium
Jane P. F. Bai et al.
MOLECULAR PHARMACEUTICS (2012)
The Role of Serum Magnesium and Calcium on the Association between Adiponectin Levels and All-Cause Mortality in End-Stage Renal Disease Patients
Anastasia Markaki et al.
PLOS ONE (2012)
Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability
Angel L. M. de Francisco et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Long-term effects of magnesium carbonate on coronary artery calcification and bone mineral density in hemodialysis patients: A pilot study
David M. Spiegel et al.
HEMODIALYSIS INTERNATIONAL (2009)
Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis
Faruk Turgut et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2008)
Magnesium carbonate for phosphate control in patients on hemodialysis. A randomized controlled trial
Ioannis P. Tzanakis et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2008)
Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients: A pilot study
David M. Spiegel et al.
JOURNAL OF RENAL NUTRITION (2007)
The role of magnesium binders in chronic kidney disease
David M. Spiegel
SEMINARS IN DIALYSIS (2007)
Hypomagnesemia in patients with type 2 diabetes
Phuong-Chi T. Pham et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Inverse correlation between serum magnesium and parathyroid hormone in peritoneal dialysis patients: a contributing factor to adynamic bone disease?
Mingxin Wei et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2006)
Dialysate magnesium level and blood pressure
J Kyriazis et al.
KIDNEY INTERNATIONAL (2004)
Low vs standard calcium dialysate in peritoneal dialysis:: differences in treatment, biochemistry and bone histomorphometry.: A randomized multicentre study
C Sánchez et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Maintenance hemodialysis and circulating ionized magnesium
AC Truttmann et al.
NEPHRON (2002)